{"query":"protagonist-inc.com","mode":"domain","best":{"domain":"protagonist-inc.com","status":"valid","tier":"listed","authority":47,"verified":false,"title":"www.protagonist-inc.com","summary":"Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.","country":null,"country_source":"cdn","llms_txt":"https://www.protagonist-inc.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-21T12:57:08.223Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["biopharmaceutical","peptide drugs","rusfertide","clinical trials","drug pipeline"],"audience":"mixed","agent_uses":["read_docs","search_content"],"language":"en","platform_generated":false,"agent_summary":"Protagonist Therapeutics: clinical-stage biopharma developing peptide-based drugs; pipeline, clinical trial news, and stock info.","llms_txt_cached":"https://agentwebmap.com/v1/domain/protagonist-inc.com/llms.txt","agentic":"documentation","section_keys":["blog-posts","pages"],"section_partial":false,"section_indexed_at":"2026-10-21T14:18:56.166Z","why":["authority 47 (listed)","checked 2158 minutes ago"]},"read":{"llms_txt":"https://www.protagonist-inc.com/llms.txt","llms_full_txt":null,"nested_llms_txt":[]},"terms":null,"health":{"ok":true,"status":"valid","tier":"listed","authority":47,"last_checked":"2026-10-21T12:57:08.223Z","checked_minutes_ago":2157,"stale":true,"max_age_seconds":86400,"live_checked":false,"http_status":200,"last_valid":"2026-10-21T12:57:08.223Z","content_hash":"c5a0a18c0793c946d7444f1c7dea4bdf"},"sources":[],"match":{"strength":"domain","reason":"Exact domain or its registered publisher."},"provenance":{"selection":"directory","verification":"domain_ownership","terms":"unknown","excerpts":"publisher_link_metadata","health":"stored_crawl"},"alternatives":[]}